FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Dr. Reddy's Laboratories Omeprazole Delayed-release Capsules Recall

Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufacture…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Jul 23, 2025
Recall ID
D-0525-2025
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Omeprazole Delayed-release Capsules starting Jun 30, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0525-2025 on Jul 23, 2025. Reason: Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules. Status: Ongoing.

Why it was recalled

Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.

Product description

Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10

Lot numbers, UPCs & expiration codes

Lot: C2403017, Exp 12/31/2026

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0525-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jun 30, 2025
FDA report date
Jul 23, 2025
Quantity
1476 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0525-2025, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
97161
Address
107 College Rd E
Code information
Lot: C2403017, Exp 12/31/2026
Postal code
08540-6623
Report date
Jul 23, 2025
Product type
Drugs
Recall number
D-0525-2025
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
1476 bottles
Reason for recall
Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10
Distribution pattern
USA Nationwide
Recall initiation date
Jun 30, 2025
Initial firm notification
Letter
Center classification date
Jul 14, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0525-2025, published Jul 23, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls